This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Puranen, T. Articles by Vihko, R. Search for Related Content PubMed PubMed Citation Articles by Puranen, T. Articles by Vihko, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL ESTRONE L-SERINE

Characterization of Structural and Functional Properties of Human 17ß-Hydroxysteroid Dehydrogenase Type 1 Using Recombinant Enzymes and Site-Directed Mutagenesis

Biocenter Oulu and Department of Clinical Chemistry (T.P., M.P., P.V., R.V.) University of Oulu FIN-90220 Oulu, Finland
Hauptman-Woodward Medical Research Institute, Inc. (D.G.) Buffalo, New York 14203
Roswell Park Cancer Institute (D.G.) Buffalo, New York 14263

Human 17ß-hydroxysteroid dehydrogenase (17-HSD) type 1 catalyzes the conversion of the low activity estrogen, estrone, into highly active estradiol, both in the gonads and in target tissues. The present study was carried out to characterize the dimerization, microheterogeneity, and phosphorylation of human 17-HSD type 1 and to evaluate the current model of hydride transfer and substrate recognition of the enzyme, based on its x-ray structure. 17-HSD type 1 is a homodimer consisting of noncovalently bound subunits, and the data in the present study indicate an exceptionally strong association between the monomers [dissociation constant (K_d) < 5 pmol/liter]. Furthermore, substitutions constructed at the hydrophobic dimer interface always resulted in inactive aggregates of the protein. The enzyme was shown to be phosphorylated by protein kinase A exclusively at Ser¹³⁴ only in vitro. However, in contrast to previous suggestions, phosphorylation of Ser¹³⁴ was shown to play no role in the activity or microheterogeneity of human 17-HSD type 1. The presence of microheterogeneity in the recombinant enzyme also indicates that it does not result from the frequent protein polymorphism previously found for the enzyme. In line with the x-ray structure and the proposed catalytic mechanism of the enzyme, our results indicate that Ser¹⁴², Tyr¹⁵⁵, and Lys¹⁵⁹ are all critical for hydride transfer in human 17-HSD type 1. In contrast, the proposed interaction between His²²¹, Glu²⁸², and the 3-OH group of the steroid at the substrate recognition helix could not be shown to exist. Neither of these residues plays a critical role in the catalytic action of the enzyme in cultured cells.

This article has been cited by other articles:

				N. Takahashi-Shiga, H. Utsunomiya, Y. Miki, S. Nagase, R. Kobayashi, M. Matsumoto, H. Niikura, K. Ito, and N. Yaegashi Local Biosynthesis of Estrogen in Human Endometrial Carcinoma through Tumor-Stromal Cell Interactions Clin. Cancer Res., October 1, 2009; 15(19): 6028 - 6034. [Abstract] [Full Text] [PDF]

				J. M Day, H. J Tutill, A. Purohit, and M. J Reed Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692. [Abstract] [Full Text] [PDF]

				L Y Zhou, D S Wang, B Senthilkumaran, M Yoshikuni, Y Shibata, T Kobayashi, C C Sudhakumari, and Y Nagahama Cloning, expression and characterization of three types of 17{beta}-hydroxysteroid dehydrogenases from the Nile tilapia, Oreochromis niloticus J. Mol. Endocrinol., August 1, 2005; 35(1): 103 - 116. [Abstract] [Full Text] [PDF]

				A. H. Payne and D. B. Hales Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones Endocr. Rev., December 1, 2004; 25(6): 947 - 970. [Abstract] [Full Text] [PDF]

				T. Nozawa, M. Suzuki, K. Takahashi, H. Yabuuchi, T. Maeda, A. Tsuji, and I. Tamai Involvement of Estrone-3-Sulfate Transporters in Proliferation of Hormone-Dependent Breast Cancer Cells J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1032 - 1037. [Abstract] [Full Text] [PDF]

				O. O. Oduwole, Y. Li, V. V. Isomaa, A. Mantyniemi, A. E. Pulkka, Y. Soini, and P. T. Vihko 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Is an Independent Prognostic Marker in Breast Cancer Cancer Res., October 15, 2004; 64(20): 7604 - 7609. [Abstract] [Full Text] [PDF]

				J. L. Thomas, J. I. Mason, S. Brandt, B. R. Spencer Jr., and W. Norris Structure/Function Relationships Responsible for the Kinetic Differences between Human Type 1 and Type 2 3beta -Hydroxysteroid Dehydrogenase and for the Catalysis of the Type 1 Activity J. Biol. Chem., November 1, 2002; 277(45): 42795 - 42801. [Abstract] [Full Text] [PDF]

				F. Beaudoin, K. Gable, O. Sayanova, T. Dunn, and J. A. Napier A Saccharomyces cerevisiae Gene Required for Heterologous Fatty Acid Elongase Activity Encodes a Microsomal beta -Keto-reductase J. Biol. Chem., March 22, 2002; 277(13): 11481 - 11488. [Abstract] [Full Text] [PDF]

				Y.-W. Huang, I. Pineau, H.-J. Chang, A. Azzi, V. Bellemare, S. Laberge, and S.-X. Lin Critical Residues for the Specificity of Cofactors and Substrates in Human Estrogenic 17{beta}-Hydroxysteroid Dehydrogenase 1: Variants Designed from the Three-Dimensional Structure of the Enzyme Mol. Endocrinol., November 1, 2001; 15(11): 2010 - 2020. [Abstract] [Full Text] [PDF]

				T. J. Puranen, R. M. Kurkela, J. T. Lakkakorpi, M. H. Poutanen, P. V. Itäranta, J. P. J. Melis, D. Ghosh, R. K. Vihko, and P. T. Vihko Characterization of Molecular and Catalytic Properties of Intact and Truncated Human 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Enzymes: Intracellular Localization of the Wild-Type Enzyme in the Endoplasmic Reticulum Endocrinology, July 1, 1999; 140(7): 3334 - 3341. [Abstract] [Full Text]

				A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82. [Abstract] [Full Text] [PDF]

				M. W. Sawicki, M. Erman, T. Puranen, P. Vihko, and D. Ghosh Structure of the ternary complex of human 17beta -hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+ PNAS, February 2, 1999; 96(3): 840 - 845. [Abstract] [Full Text] [PDF]

				P. Nokelainen, H. Peltoketo, R. Vihko, and P. Vihko Expression Cloning of a Novel Estrogenic Mouse 17{beta}-Hydroxysteroid Dehydrogenase/ 17-Ketosteroid Reductase (m17HSD7), Previously Described as a Prolactin Receptor-Associated Protein (PRAP) in Rat Mol. Endocrinol., July 1, 1998; 12(7): 1048 - 1059. [Abstract] [Full Text]

				T. Puranen, M. Poutanen, D. Ghosh, R. Vihko, and P. Vihko Origin of Substrate Specificity of Human and Rat 17{beta}-Hydroxysteroid Dehydrogenase Type 1, Using Chimeric Enzymes and Site-Directed Substitutions Endocrinology, August 1, 1997; 138(8): 3532 - 3539. [Abstract] [Full Text]

				D. Ghosh, M. Sawicki, V. Pletnev, M. Erman, S. Ohno, S. Nakajin, and W. L. Duax Porcine Carbonyl Reductase. STRUCTURAL BASIS FOR A FUNCTIONAL MONOMER IN SHORT CHAIN DEHYDROGENASES/REDUCTASES J. Biol. Chem., May 18, 2001; 276(21): 18457 - 18463. [Abstract] [Full Text] [PDF]